• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    6/20/24 1:26:29 PM ET
    $ALUR
    $AMD
    $APLD
    $ASNS
    Medical/Dental Instruments
    Health Care
    Semiconductors
    Technology
    Get the next $ALUR alert in real time by email

    Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.

    Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, beating the analyst consensus estimate of $6.53 billion. The print manufacturing company's adjusted EPS of $1.89 beat the analyst consensus of $1.85, according to data from Benzinga Pro.

    Jabil said it expects fourth-quarter revenue of $6.3 billion – $6.9 billion (consensus: $6.8 billion) and adjusted EPS to $2.03 – $2.43 (consensus: $2.22).

    Jabil shares dipped 7.8% to $116.37 on Thursday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • MGO Global, Inc. (NASDAQ:MGOL) shares jumped 222.8% to $1.48 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.
    • Griid Infrastructure Inc. (NASDAQ:GRDI) climbed 89.3% to $1.48 after falling more than 10% on Tuesday.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) gained 89% to $2.58 after the company said it expects first customer deliveries of the i300 in the fourth quarter and anticipates selling over 5,000 units in the fiscal year ending September 30, 2025.
    • Reliance Global Group, Inc. (NASDAQ:RELI) shares climbed 60.5% to $0.6279. Reliance Global Group announced major enhancement of capital structure following cashless exercise of warrants.
    • Allurion Technologies Inc. (NYSE:ALUR) gained 50% to $1.598. Allurion announced publication of new data demonstrating lean mass gains in patients experiencing 14% weight loss.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 43% to $0.1702 after jumping 19% on Tuesday.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) gained 23.3% to $5.96.
    • Femasys Inc. (NASDAQ:FEMY) rose 22% to $1.1650 after receiving CE Mark approval from the EU MDR for its FemaSeed, FemVue, FemCerv, and FemCath products.
    • Molecular Partners AG (NASDAQ:MOLN) shares rose 21.1% to $9.63 after gaining 9% on Tuesday.
    • Surf Air Mobility Inc. (NASDAQ:SRFM) jumped 20.6% to $0.3850.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 20.2% to $3.75.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) surged 19.7% to $1.1303. MicroCloud Hologram entered into convertible note purchase agreements with investors for $28 million on June 18.
    • Presto Automation Inc. (NASDAQ:PRST) shares climbed 19.2% to $0.0877after falling around 5% on Tuesday.
    • NanoViricides, Inc. (NASDAQ:NNVC) gained 16.5% to $1.91. Nanoviricides reported that the ultra-broad-spectrum antiviral NV-387, a Phase 2 Stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected influenza H3N2 mouse model.
    • Lobo EV Technologies Ltd. (NASDAQ:LOBO) rose 16.4% to $2.47.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) gained 16% to $6.36 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $7 to $11.
    • Applied Digital Corporation (NASDAQ:APLD) jumped 15.3% to $5.95.
    • Ranpak Holdings Corp. (NYSE:PACK) climbed 13.7% to $6.49.
    • ImmunityBio, Inc. (NASDAQ:IBRX) rose 13.6% to $7.08 after the company announced insurance coverage of ANKTIVA across multiple states with first commercial doses administered.
    • Harrow, Inc. (NASDAQ:HROW) gained 12.2% to $19.81 after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company announced that the second and third required PPQ batches are now scheduled.
    • ZKH Group Limited (NYSE:ZKH) rose 11.4% to $3.92
    • NANO Nuclear Energy Inc. (NASDAQ:NNE) gained 11.3% to $12.91.
    • Himax Technologies, Inc. (NASDAQ:HIMX) jumped 11.1% to $8.23
    • UTime Limited (NASDAQ:WTO) surged 11% to $0.5849
    • Nexalin Technology, Inc. (NASDAQ:NXL) gained 10% to $1.1450. Nexalin Technology shares jumped around 38% on Tuesday after the company was awarded a US patent on ‘Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and Dementia.’
    • Bilibili Inc. (NASDAQ:BILI) shares climbed 7.8% to $17.45. On Tuesday, JP Morgan analyst Daniel Chen upgraded Bilibili from Neutral to Overweight and announced a $21 price target.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) gained 7% to $982.60 after Elon Musk indicated the company will provide server racks for the supercomputer that xAI is building.
    • Advanced Micro Devices, Inc. (NASDAQ:AMD) rose 5% to $162.36.

    Losers

    • Trevena, Inc. (NASDAQ:TRVN) fell 43.7% to $0.1993. Trevena announced preclinical TRV045 data for long-term analgestic effect in prelinical model of neuropathic pain. Also, the company announced TRV045 results provided director for additional NIH-initiated studies in epilepsy prevention and treatment.
    • Kaival Brands Innovations Group, Inc (NASDAQ:KAVL) shares declined 33.5% to $2.99 after gaining 8% on Tuesday.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) fell 29% to $1.10. Sonnet BioTherapeutics announced exercise of warrants for gross proceeds of $3.4 million.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) declined 25% to $2.1208. The company announced new data from the ongoing Phase 1b/2 clinical study on amezalpat2 (TPST-1120).
    • Nikola Corporation (NASDAQ:NKLA) declined 23.6% to $0.3672. Nikola announced 1-for-30 reverse stock split approved by board.
    • La Rosa Holdings Corp. (NASDAQ:LRHC) shares fell 23.5% to $1.37. La Rosa Holdings shares jumped 72% on Tuesday after the company entered a non-binding letter of intent to acquire a controlling interest in Red Door Title.
    • SYLA Technologies Co., Ltd. (NASDAQ:SYT) dipped 21.7% to $1.70.
    • Mustang Bio, Inc. (NASDAQ:MBIO) shares dipped 21% to $0.6721 after the company announced a $2.5 million registered direct offering of 6.130 million shares at $0.41 per share.
    • QXO, Inc. (NASDAQ:QXO) fell 20.9% to $72.55.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) tumbled 20.3% to $0.1910 after jumping 82% on Tuesday.
    • DermTech, Inc. (NASDAQ:DMTK) fell 19.4% to $0.1176.
    • Dunxin Financial Holdings Limited (NASDAQ:DXF) shares fell 19.4% to $0.1728 after dipping 17% on Tuesday.
    • Tempus AI, Inc (NASDAQ:TEM) fell 15.1% to $25.76 amid post-IPO volatility.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) declined 15% to $2.2991 after B of A Securities downgraded the stock from Neutral to Underperform.
    • SRIVARU Holding Limited (NASDAQ:SVMH) shares fell 13.7% to $0.2150. SRIVARU, last week, announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
    • Actelis Networks, Inc. (NASDAQ:ASNS) fell 12.2% to $1.8602. Actelis Networks shares jumped 84% on Tuesday after the company announced an agreement to serve as Carahsoft’s public sector distributor.
    • Jasper Therapeutics, Inc. (NASDAQ:JSPR) declined 10.1% to $20.84. Jasper Therapeutics announced appointment of Svetlana Lucas Ph.D., to its Board of Directors.
    • GMS Inc. (NYSE:GMS) declined 6.5% to $84.02 after the company reported mixed fourth-quarter financial results.
    • Nayax Ltd. (NASDAQ:NYAX) fell 6.1% to $21.23.
    • Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) fell 5% to $6.03 after the company’s board determined that recent takeover proposals were not in its best interests.

    Now Read This: This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

    Get the next $ALUR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALUR
    $AMD
    $APLD
    $ASNS

    CompanyDatePrice TargetRatingAnalyst
    Advanced Micro Devices Inc.
    $AMD
    4/24/2026$375.00Neutral → Buy
    DA Davidson
    Advanced Micro Devices Inc.
    $AMD
    4/16/2026$235.00 → $265.00Mkt Perform
    Bernstein
    Tempus AI Inc.
    $TEM
    4/13/2026$35.00Underperform
    Jefferies
    Tempus AI Inc.
    $TEM
    4/13/2026$65.00Hold → Buy
    TD Cowen
    Bilibili Inc.
    $BILI
    4/13/2026$31.00Equal-Weight → Overweight
    Morgan Stanley
    Advanced Micro Devices Inc.
    $AMD
    4/3/2026Hold → Buy
    Erste Group
    Advanced Micro Devices Inc.
    $AMD
    4/2/2026Hold → Buy
    Erste Group
    Bilibili Inc.
    $BILI
    3/27/2026$27.00Neutral → Buy
    Citigroup
    More analyst ratings

    $ALUR
    $AMD
    $APLD
    $ASNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $15,605 worth of Class A Shares (14,584 units at $1.07) and sold $9,121 worth of Class A Shares (8,368 units at $1.09), increasing direct ownership by 15% to 48,596 units (SEC Form 4)

    4 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/3/26 2:57:47 PM ET
    $LRHC
    Real Estate
    Finance

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Tempus Ai, Inc. bought $2,739,181 worth of shares (320,267 units at $8.55), increasing direct ownership by 3% to 13,039,067 units (SEC Form 4)

    4 - Tempus AI, Inc. (0001717115) (Reporting)

    2/13/26 5:24:46 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $ALUR
    $AMD
    $APLD
    $ASNS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for FANAPT issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug FANAPT (SUPPL-23) with active ingredient ILOPERIDONE has changed to 'Approval' on 04/02/2024. Application Category: NDA, Application Number: 022192, Application Classification: Efficacy

    4/3/24 4:12:36 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALUR
    $AMD
    $APLD
    $ASNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim CFO Bader Amir was granted 200,000 units of Ordinary Shares, increasing direct ownership by 184% to 308,846 units (SEC Form 4)

    4 - SMX (Security Matters) Public Ltd Co (0001940674) (Issuer)

    4/24/26 5:18:06 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    Chairman & CEO Alon Haggai was granted 2,000,000 units of Ordinary Shares, increasing direct ownership by 891% to 2,224,501 units (SEC Form 4)

    4 - SMX (Security Matters) Public Ltd Co (0001940674) (Issuer)

    4/24/26 5:18:05 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    New insider Alon Haggai claimed ownership of 224,501 units of Ordinary Shares (SEC Form 3)

    3 - SMX (Security Matters) Public Ltd Co (0001940674) (Issuer)

    4/24/26 5:16:06 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $ALUR
    $AMD
    $APLD
    $ASNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Actelis Networks Commences Trading on the OTCQB Venture Market

    SUNNYVALE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (OTCQB:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced that its common stock has commenced trading on the OTCQB Venture Market operated by OTC Markets Group, effective at the open of business on April 24, 2026. The Company's common stock continues to trade under the symbol "ASNS." The transition to OTCQB follows the Company's previously announced move from The Nasdaq Capital Market to the OTC Markets, and the Company's application to the OTCQB Venture Market. OTCQB is a marketplace designed for devel

    4/24/26 10:27:19 AM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    ZKH Group Limited Files Its 2025 Annual Report on Form 20-F

    SHANGHAI, April 24, 2026 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE:ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform in China, announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC") on April 24, 2026. The annual report in electronic format is accessible on the Company's investor relations website at https://ir.zkh.com as well as on the SEC's website at www.sec.gov. For those who prefer hard copies, the Company will provide the annual report, containing audited consolidated financial statements, free of charge to shareholders and ADS

    4/24/26 7:30:00 AM ET
    $ZKH
    RETAIL: Building Materials
    Consumer Discretionary

    Jabil Declares Quarterly Dividend

    Jabil Inc. (NYSE:JBL) today announced that its Board of Directors declared a quarterly dividend of $0.08 per share of common stock to shareholders of record as of May 15, 2026. The dividend is payable on June 2, 2026. Jabil has paid consecutive quarterly cash dividends on its common shares since May 15, 2006. About Jabil: At Jabil (NYSE:JBL), we are proud to be a trusted partner for the world's top brands, offering comprehensive engineering, supply chain, and manufacturing solutions. With 60 years of experience across industries and a vast network of over 100 sites worldwide, Jabil combines global reach with local expertise to deliver both scalable and customized solutions. Our commit

    4/23/26 4:15:00 PM ET
    $JBL
    Electrical Products
    Technology

    $ALUR
    $AMD
    $APLD
    $ASNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Advanced Micro Devices upgraded by DA Davidson with a new price target

    DA Davidson upgraded Advanced Micro Devices from Neutral to Buy and set a new price target of $375.00

    4/24/26 7:59:47 AM ET
    $AMD
    Semiconductors
    Technology

    Bernstein reiterated coverage on Advanced Micro Devices with a new price target

    Bernstein reiterated coverage of Advanced Micro Devices with a rating of Mkt Perform and set a new price target of $265.00 from $235.00 previously

    4/16/26 12:58:56 PM ET
    $AMD
    Semiconductors
    Technology

    Jefferies initiated coverage on Tempus AI with a new price target

    Jefferies initiated coverage of Tempus AI with a rating of Underperform and set a new price target of $35.00

    4/13/26 9:01:23 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $ALUR
    $AMD
    $APLD
    $ASNS
    SEC Filings

    View All

    La Rosa Holdings Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

    8-K - La Rosa Holdings Corp. (0001879403) (Filer)

    4/24/26 5:28:37 PM ET
    $LRHC
    Real Estate
    Finance

    Surf Air Mobility Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - SURF AIR MOBILITY INC. (0001936224) (Filer)

    4/24/26 5:20:16 PM ET
    $SRFM
    Transportation Services
    Consumer Discretionary

    SEC Form 6-K filed by SMX (Security Matters) Public Limited Company

    6-K - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    4/24/26 5:15:02 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $ALUR
    $AMD
    $APLD
    $ASNS
    Leadership Updates

    Live Leadership Updates

    View All

    Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors

    WASHINGTON, April 22, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced the appointment of Charles Duncan, Ph.D. to its Board of Directors effective April 22, 2026. Following Dr. Duncan's appointment, Vanda's Board of Directors is now comprised of seven directors, six of whom are independent. Dr. Duncan is a highly experienced and respected leader in the life sciences and biotechnology sector," said Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board. "We are excited to welcome him to our strong and independent Boa

    4/22/26 5:13:00 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    QXO to Acquire TopBuild for $17 Billion

    QXO to Become the Second Largest Publicly Traded Building Products Distributor in North America, with More Than $18 Billion of Combined Company Revenue and More Than $2 Billion of Combined Company Adjusted EBITDA Landmark Transaction Is Expected to Be Immediately and Substantially Accretive to QXO's Earnings QXO, Inc. (NYSE:QXO) today announced that it has entered into a definitive agreement to acquire TopBuild Corp. (NYSE:BLD) ("TopBuild") for approximately $17 billion, significantly expanding QXO's scale and capabilities across the building products value chain. The transaction is expected to be immediately and substantially accretive to the company's earnings. TopBuild is the large

    4/19/26 1:00:00 PM ET
    $BLD
    $QXO
    Engineering & Construction
    Consumer Discretionary
    RETAIL: Building Materials

    Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

    Adds dedicated business development leadership to support Tempest's strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering discussions for Phase 3-ready amezalpat program, including potential China development opportunities BRISBANE, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the appointment of Andrew Fang, Ph.D., as Head of Business Development. Dr. Fang will lead Tempest's global business development efforts, including strategic partners

    4/14/26 8:00:00 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALUR
    $AMD
    $APLD
    $ASNS
    Financials

    Live finance-specific insights

    View All

    Jabil Declares Quarterly Dividend

    Jabil Inc. (NYSE:JBL) today announced that its Board of Directors declared a quarterly dividend of $0.08 per share of common stock to shareholders of record as of May 15, 2026. The dividend is payable on June 2, 2026. Jabil has paid consecutive quarterly cash dividends on its common shares since May 15, 2006. About Jabil: At Jabil (NYSE:JBL), we are proud to be a trusted partner for the world's top brands, offering comprehensive engineering, supply chain, and manufacturing solutions. With 60 years of experience across industries and a vast network of over 100 sites worldwide, Jabil combines global reach with local expertise to deliver both scalable and customized solutions. Our commit

    4/23/26 4:15:00 PM ET
    $JBL
    Electrical Products
    Technology

    Esperion to Report First Quarter 2026 Financial Results on May 7

    ANN ARBOR, Mich., April 23, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced it will report first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. About Esperion Therapeutics Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical c

    4/23/26 8:00:00 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ranpak to Hold Conference Call to Discuss First Quarter 2026 Results

    Ranpak Holdings Corp. (NYSE:PACK) announced today that it will release its first quarter results at approximately 7:30 a.m. (ET) on Thursday, April 30, 2026 and will host a conference call and webcast at 8:30 a.m. (ET) on that day. The conference call and earnings presentation will be webcast live at the following link: https://events.q4inc.com/attendee/715712603. Investors who cannot access the webcast may listen to the conference call live via telephone by dialing (800) 715-9871 and use the Conference ID: 5140125. A telephonic replay of the webcast also will be available starting at 11:30 a.m. (ET) on Thursday, April 30, 2026 and ending at 11:59 p.m. (ET) on Thursday, May 7, 2026. To

    4/22/26 7:30:00 AM ET
    $PACK
    Containers/Packaging
    Consumer Discretionary

    $ALUR
    $AMD
    $APLD
    $ASNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by SYLA Technologies Co. Ltd.

    SC 13D/A - SYLA Technologies Co., Ltd. (0001946216) (Subject)

    12/10/24 6:03:39 AM ET
    $SYT
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Harrow Inc.

    SC 13G/A - HARROW, INC. (0001360214) (Subject)

    12/5/24 7:08:52 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care